Table 2 Thrombin inhibition activity of the compounds in DQP.

From: A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines

Compounds

Chemical family

Inhibition (%) a

IC50 (μM)

Tanshinol

SA

4.13 ± 1.19

ND b

Protocatechuic aldehyde

SA

−1.49 ± 3.18

ND b

Rosmarinic acid

SA

−1.70 ± 0.54

ND b

Lithospermic acid

SA

−0.89 ± 0.83

ND b

Salvianolic acid B

SA

−0.91 ± 0.00

ND b

Salvianolic acid A

SA

−0.82 ± 1.88

ND b

Ginsenoside-Rg1

GS

−6.73 ± 1.01 c

ND b

Ginsenoside-Rh1

GS

−9.24 ± 1.99 c

ND b

Ginsenoside-Rd

GS

−11.64 ± 2.97 c

ND b

Ginsenoside-Rb1

GS

−13.70 ± 3.71 c

ND b

Dihydrotanshinone I

TN

63.71 ± 3.13

92 ± 5

Cryptotanshinone

TN

56.01 ± 2.21

102 ± 4

Tanshinone I

TN

39.79 ± 0.40

333 ± 28

Tanshinone IIA

TN

84.12 ± 1.81

39 ± 1

Argatroban

Positive control

99.46 ± 0.33

17 ± 1 d

  1. aThe concentration of each reference standard was 125 μM.
  2. bND: not detected.
  3. cThe negative value means promotion effect on thrombin.
  4. dThe unit is nanomole.